Evidence map›Paper›PMID 20720586›Full record

ReviewNature immunology2010

Complement: a key system for immune surveillance and homeostasis.

Daniel Ricklin, George Hajishengallis, Kun Yang, John D Lambris

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Nature immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,956 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,956citing papers in PubMed, 4 pooled it
63.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03791476 phase1unknown statusnot on this mapstarted 2019, after this paper: background citation

A Phase I/II,Single Center,Randomized,Double-Blind,Placebo-Controlled Study to Evaluate the Feasibility of Using Human Recombinant C1 Inhibitor(RUCONEST®) as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function in Recipients of Kidneys From Donation After Cardio-Circulatory Death

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2019 to 2022Enrolled20ConditionsKidney FailureArmsrhC1INH, Saline Solution
NCT06495151 completednot on this mapstarted 2022, after this paper: background citation

Evaluation of Serum and Peritoneal Fluid Mannose-binding Lectin Associated Serine Protease-3, Adipsin, Properdin, and Complement Factor H Levels in Endometriosis Patients

TypeobservationalSponsorAnkara City Hospital BilkentRan2022 to 2022Enrolled58ConditionsEndometriosis, Complement System, Alternative Complement PathwayArmsMannose-binding lectin-associated serine protease-3 (MASP-3) Level, Adipsin Level, Properdin Level, Complement Factor H (CFH) Level, Cancer Antigen 125 (CA-125) Level
3 · Its place in the literature

Who cites it

1,956 citing papers in PubMed, 4 syntheses or guidelines pooled it, 3,549 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

1,896 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel RicklinDepartment of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
George Hajishengallis
Kun Yang
John D Lambris
University of Pennsylvania · USUniversity of Louisville · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
STRUCTURE-FUNCTION ANALYSIS OF DIFFERENT C3 SPECIESR01AI030040 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 1993 to 2016
$4.1M
STRUCTURAL-FUNCTIONAL ANALYSIS OF COMPSTATINR01GM062134 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2001 to 2010
$2.5M
Thermodynamic and structural studies on the formation of the C3 convertaseR01AI072106 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2011
$2.0M
Oral Pathogen Exploitation of Innate Recognition as a Function of AgeR01DE018292 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2007 to 2011
$1.6M
The role of complement in ovarian cancerR01CA112162 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2005 to 2009
$1.5M
Biomaterial-induced complement activationR01EB003968 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2005 to 2008
$1.0M
VIRAL RESPIRATORY PATHOGENS RESEARCH UNIT /VRPRU/-266030040-266030040N01AI030040 · NIAID · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2003 to 2006
–
NCI NIH HHS CA112162NCI NIH HHS R01 CA112162NIAID NIH HHS AI30040NIAID NIH HHS AI68730NIAID NIH HHS AI72106NIAID NIH HHS N01 AI030040NIAID NIH HHS P01 AI068730NIAID NIH HHS R01 AI030040NIAID NIH HHS R01 AI072106NIBIB NIH HHS EB3968NIBIB NIH HHS R01 EB003968NIDCR NIH HHS DE015254NIDCR NIH HHS DE018292NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R01 DE018292NIGMS NIH HHS GM62134NIGMS NIH HHS R01 GM062134
6 · The paper itself

Abstract

Nearly a century after the significance of the human complement system was recognized, we have come to realize that its functions extend far beyond the elimination of microbes. Complement acts as a rapid and efficient immune surveillance system that has distinct effects on healthy and altered host cells and foreign intruders. By eliminating cellular debris and infectious microbes, orchestrating immune responses and sending 'danger' signals, complement contributes substantially to homeostasis, but it can also take action against healthy cells if not properly controlled. This review describes our updated view of the function, structure and dynamics of the complement network, highlights its interconnection with immunity at large and with other endogenous pathways, and illustrates its multiple roles in homeostasis and disease.

Indexed as

ApoptosisComplement System ProteinsDiseaseGene Expression RegulationHomeostasisHumansImmunologic SurveillanceSignal TransductionComplement System Proteins

Identifiers

PMID20720586
PMCPMC2924908
OpenAlexW2136648677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.